-
1
-
-
0030913315
-
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
-
Partin, A. W., Rattan, M. W., Subong, E. N., Walsh, P. C., Wojno, K. J. and Oesterling, J. E.: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA, 277: 1445, 1997
-
(1997)
JAMA
, vol.277
, pp. 1445
-
-
Partin, A.W.1
Rattan, M.W.2
Subong, E.N.3
Walsh, P.C.4
Wojno, K.J.5
Oesterling, J.E.6
-
2
-
-
0036843923
-
Association between prostate cancer and serum testosterone levels
-
Zhang, P. L., Rosen, S., Veeramachaneni, R., Kao, J., DeWolf, W. C. and Bubley, G.: Association between prostate cancer and serum testosterone levels. Prostate, 53: 179, 2002
-
(2002)
Prostate
, vol.53
, pp. 179
-
-
Zhang, P.L.1
Rosen, S.2
Veeramachaneni, R.3
Kao, J.4
Dewolf, W.C.5
Bubley, G.6
-
3
-
-
0037812658
-
The influence of finasteride on the development of prostate cancer
-
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G. et al: The influence of finasteride on the development of prostate cancer. N Engl J Med, 349: 215, 2003
-
(2003)
N Engl J Med
, vol.349
, pp. 215
-
-
Thompson, I.M.1
Goodman, P.J.2
Tangen, C.M.3
Lucia, M.S.4
Miller, G.J.5
Ford, L.G.6
-
4
-
-
0344406150
-
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
-
Massengill, J. C., Sun, L., Moul, J. W., Wu, H., McLeod, D. G., Amling, C. et al: Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol, 169: 1670, 2003
-
(2003)
J Urol
, vol.169
, pp. 1670
-
-
Massengill, J.C.1
Sun, L.2
Moul, J.W.3
Wu, H.4
McLeod, D.G.5
Amling, C.6
-
5
-
-
0033950926
-
Is low serum free testosterone a marker for high-grade prostate cancer?
-
Hoffman, M. A., DeWolf, W. C. and Morgentaler, A.: Is low serum free testosterone a marker for high-grade prostate cancer? J Urol, 163: 824, 2000
-
(2000)
J Urol
, vol.163
, pp. 824
-
-
Hoffman, M.A.1
Dewolf, W.C.2
Morgentaler, A.3
-
6
-
-
0036224481
-
The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis
-
Chen, S. S., Chen, K. K., Lin, A. T., Chang, Y. H., Wu, H. H. and Chang, L. S.: The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis. BJU Int, 89: 710, 2002
-
(2002)
BJU Int
, vol.89
, pp. 710
-
-
Chen, S.S.1
Chen, K.K.2
Lin, A.T.3
Chang, Y.H.4
Wu, H.H.5
Chang, L.S.6
-
7
-
-
0034767957
-
Cancer burden in the year 2000. The global picture
-
Parkin, D. M., Bray, F. I. and Devesa, S. S.: Cancer burden in the year 2000. The global picture. Eur J Cancer, suppl., 37: S4, 2001
-
(2001)
Eur J Cancer
, vol.37
, Issue.SUPPL.
-
-
Parkin, D.M.1
Bray, F.I.2
Devesa, S.S.3
-
8
-
-
0012786679
-
Screening for carcinoma of the prostate in volunteers
-
Martins, A. C. P., Reis, R. B., Suaid, H. J., Maciel, L. M. Z., Cologna, A. J. and Falconi, R. A. R.: Screening for carcinoma of the prostate in volunteers. Braz J Urol, 26: 516, 2000
-
(2000)
Braz J Urol
, vol.26
, pp. 516
-
-
Martins, A.C.P.1
Reis, R.B.2
Suaid, H.J.3
Maciel, L.M.Z.4
Cologna, A.J.5
Falconi, R.A.R.6
-
9
-
-
0037388135
-
Recent trends in prostate cancer incidence and mortality in southeast England
-
Evans, H. S. and Moller, H.: Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol, 43: 337, 2003
-
(2003)
Eur Urol
, vol.43
, pp. 337
-
-
Evans, H.S.1
Moller, H.2
-
10
-
-
8444233301
-
Clinical consequences of screening for prostate cancer: 15 Years follow-up of a randomised controlled trial in Sweden
-
Sandblom, G., Varenhorst, E., Lofman, O., Rosell, J. and Carlsson, P.: Clinical consequences of screening for prostate cancer: 15 years follow-up of a randomised controlled trial in Sweden. Eur Urol, 46: 717, 2004
-
(2004)
Eur Urol
, vol.46
, pp. 717
-
-
Sandblom, G.1
Varenhorst, E.2
Lofman, O.3
Rosell, J.4
Carlsson, P.5
-
11
-
-
0036845766
-
Improved prostate cancer-specific survival and other disease parameters: Impact of prostate-specific antigen testing
-
Paquette, E. L., Sun, L., Paquette, L. R., Connelly, R., Mcleod, D. G. and Moul, J. W.: Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing. Urology, 60: 756, 2002
-
(2002)
Urology
, vol.60
, pp. 756
-
-
Paquette, E.L.1
Sun, L.2
Paquette, L.R.3
Connelly, R.4
Mcleod, D.G.5
Moul, J.W.6
-
12
-
-
0028183087
-
Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma
-
Iversen, P., Rasmussen, F. and Christensen, I. J.: Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma. Scand J Urol Nephrol Suppl, 157: 41, 1994
-
(1994)
Scand J Urol Nephrol Suppl
, vol.157
, pp. 41
-
-
Iversen, P.1
Rasmussen, F.2
Christensen, I.J.3
-
13
-
-
0032324294
-
Influence of radical prostatectomy on serum hormone levels
-
Miller, L. R., Partin, A. W., Chan, D. W., Bruzek, D. J., Dobs, A. S., Epstein, J. I. et al: Influence of radical prostatectomy on serum hormone levels. J Urol, 160: 449, 1998
-
(1998)
J Urol
, vol.160
, pp. 449
-
-
Miller, L.R.1
Partin, A.W.2
Chan, D.W.3
Bruzek, D.J.4
Dobs, A.S.5
Epstein, J.I.6
-
14
-
-
85136393621
-
Occult prostate cancer in men with low serum testosterone levels
-
Morgentaler, A., Bruning, C. O., 3rd and DeWolf, W. C.: Occult prostate cancer in men with low serum testosterone levels. JAMA, 276: 1904, 1996
-
(1996)
JAMA
, vol.1904
, pp. 276
-
-
Morgentaler, A.1
Bruning III, C.O.2
Dewolf, W.C.3
-
15
-
-
0021336526
-
Carcinoma of the prostate: Relationship of pretreatment hormone levels to survival
-
Harper, M. E., Pierrepoint, C. G. and Griffiths, K.: Carcinoma of the prostate: relationship of pretreatment hormone levels to survival. Eur J Cancer Clin Oncol, 20: 477, 1984
-
(1984)
Eur J Cancer Clin Oncol
, vol.20
, pp. 477
-
-
Harper, M.E.1
Pierrepoint, C.G.2
Griffiths, K.3
-
16
-
-
0014296416
-
Plasma testosterone levels in patients with prostatic carcinoma before and after treatment
-
Young, H. H., 2nd and Kent, J. R.: Plasma testosterone levels in patients with prostatic carcinoma before and after treatment. J Urol, 99: 788, 1968
-
(1968)
J Urol
, vol.99
, pp. 788
-
-
Young II, H.1
Kent, J.R.2
-
17
-
-
0015222344
-
Effect of hormonal therapy on plasma testosterone levels in prostatic cancer
-
Robinson, M. R. and Thomas, B. S.: Effect of hormonal therapy on plasma testosterone levels in prostatic cancer. Br Med J, 4: 391, 1971
-
(1971)
Br Med J
, vol.4
, pp. 391
-
-
Robinson, M.R.1
Thomas, B.S.2
-
18
-
-
0026021087
-
Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group
-
Chodak, G. W., Vogelzang, N. J., Caplan, R. J., Soloway, M. and Smith, J. A.: Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. JAMA, 265: 618, 1991
-
(1991)
JAMA
, vol.265
, pp. 618
-
-
Chodak, G.W.1
Vogelzang, N.J.2
Caplan, R.J.3
Soloway, M.4
Smith, J.A.5
-
19
-
-
0023573211
-
Steroid hormone concentrations in relation to patient prognosis and prostate tumour grade
-
Harper, M. E., Wilson, D. W., Jensen, H. M., Pierrepoint, C. G. and Griffiths, K.: Steroid hormone concentrations in relation to patient prognosis and prostate tumour grade. J Steroid Biochem, 27: 521, 1987
-
(1987)
J Steroid Biochem
, vol.27
, pp. 521
-
-
Harper, M.E.1
Wilson, D.W.2
Jensen, H.M.3
Pierrepoint, C.G.4
Griffiths, K.5
-
20
-
-
0030891205
-
Serum testosterone-a significant determinant of metastatic relapse for irradiated localized prostate cancer
-
Zagars, G. K., Pollack, A. and von Eschenbach, A. C.: Serum testosterone-a significant determinant of metastatic relapse for irradiated localized prostate cancer. Urology, 40: 327, 1997
-
(1997)
Urology
, vol.40
, pp. 327
-
-
Zagars, G.K.1
Pollack, A.2
Von Eschenbach, A.C.3
|